Kate Vandyke

2.0k total citations
47 papers, 1.3k citations indexed

About

Kate Vandyke is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Kate Vandyke has authored 47 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Hematology, 27 papers in Molecular Biology and 15 papers in Oncology. Recurrent topics in Kate Vandyke's work include Multiple Myeloma Research and Treatments (27 papers), Protein Degradation and Inhibitors (10 papers) and Chemokine receptors and signaling (8 papers). Kate Vandyke is often cited by papers focused on Multiple Myeloma Research and Treatments (27 papers), Protein Degradation and Inhibitors (10 papers) and Chemokine receptors and signaling (8 papers). Kate Vandyke collaborates with scholars based in Australia, United States and Canada. Kate Vandyke's co-authors include Andrew C.W. Zannettino, Krzysztof M. Mrozik, Stephen Fitter, Chee Man Cheong, Orest W. Blaschuk, Stan Gronthos, D. Hewett, Timothy P. Hughes, Andrea L. Dewar and Jacqueline E. Noll and has published in prestigious journals such as Blood, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Kate Vandyke

44 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kate Vandyke Australia 22 709 418 411 188 182 47 1.3k
B Nico Italy 16 899 1.3× 374 0.9× 379 0.9× 213 1.1× 179 1.0× 22 1.5k
Dora Višnjić Croatia 17 724 1.0× 535 1.3× 249 0.6× 104 0.6× 296 1.6× 40 1.4k
Fotis Asimakopoulos United States 20 538 0.8× 443 1.1× 557 1.4× 194 1.0× 105 0.6× 40 1.3k
Isabelle Vande Broek Belgium 18 643 0.9× 580 1.4× 480 1.2× 223 1.2× 238 1.3× 41 1.2k
Sophia K. Khaldoyanidi United States 24 788 1.1× 441 1.1× 389 0.9× 151 0.8× 223 1.2× 50 1.7k
Marina Bolzoni Italy 19 562 0.8× 635 1.5× 610 1.5× 137 0.7× 122 0.7× 51 1.2k
Quteba Ebrahem United States 18 808 1.1× 244 0.6× 222 0.5× 408 2.2× 75 0.4× 31 1.5k
Natasha M. Savage United States 18 488 0.7× 202 0.5× 557 1.4× 161 0.9× 116 0.6× 79 1.4k
Sabrina Bonomini Italy 23 893 1.3× 949 2.3× 1.0k 2.5× 175 0.9× 267 1.5× 49 2.0k
Ryohichi Sugimura Hong Kong 14 902 1.3× 303 0.7× 254 0.6× 224 1.2× 147 0.8× 48 1.4k

Countries citing papers authored by Kate Vandyke

Since Specialization
Citations

This map shows the geographic impact of Kate Vandyke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kate Vandyke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kate Vandyke more than expected).

Fields of papers citing papers by Kate Vandyke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kate Vandyke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kate Vandyke. The network helps show where Kate Vandyke may publish in the future.

Co-authorship network of co-authors of Kate Vandyke

This figure shows the co-authorship network connecting the top 25 collaborators of Kate Vandyke. A scholar is included among the top collaborators of Kate Vandyke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kate Vandyke. Kate Vandyke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Panagopoulos, Vasilios, Melissa Cantley, D. Hewett, et al.. (2025). Age-related mesenchymal stromal cell senescence is associated with progression from MGUS to multiple myeloma. Leukemia. 39(6). 1464–1475. 3 indexed citations
2.
Vandyke, Kate, Bradley Augustson, Georgia McCaughan, et al.. (2025). Updated guidelines in the treatment of myeloma bone disease in 2025: consensus statement by the Medical and Scientific Advisory Group of Australia (MSAG) to Myeloma Australia. Expert Review of Hematology. 19(2). 133–142.
3.
4.
Fitter, Stephen, et al.. (2024). Molecular and cellular mechanisms of chemoresistance in paediatric pre–B cell acute lymphoblastic leukaemia. Cancer and Metastasis Reviews. 43(4). 1385–1399. 2 indexed citations
5.
Panagopoulos, Vasilios, et al.. (2023). Mesenchymal stromal cell senescence in haematological malignancies. Cancer and Metastasis Reviews. 42(1). 277–296. 21 indexed citations
6.
Noll, Jacqueline E., Makutiro G. Masavuli, Branka Grubor‐Bauk, et al.. (2023). Myeloperoxidase creates a permissive microenvironmental niche for the progression of multiple myeloma. British Journal of Haematology. 203(4). 614–624. 4 indexed citations
7.
Ebert, Lisa M., Kate Vandyke, M. Zahied Johan, et al.. (2021). Desmoglein‐2 expression is an independent predictor of poor prognosis patients with multiple myeloma. Molecular Oncology. 16(6). 1221–1240. 11 indexed citations
8.
Vandyke, Kate. (2021). Seed and soil revisited in multiple myeloma. Blood. 137(17). 2282–2283. 1 indexed citations
9.
Vandyke, Kate, et al.. (2021). Macrophages in multiple myeloma: key roles and therapeutic strategies. Cancer and Metastasis Reviews. 40(1). 273–284. 17 indexed citations
10.
Zeissig, Mara N., Andrew C.W. Zannettino, & Kate Vandyke. (2020). Tumour Dissemination in Multiple Myeloma Disease Progression and Relapse: A Potential Therapeutic Target in High-Risk Myeloma. Cancers. 12(12). 3643–3643. 5 indexed citations
11.
Clark, Kimberley C., D. Hewett, Vasilios Panagopoulos, et al.. (2020). Targeted Disruption of Bone Marrow Stromal Cell-Derived Gremlin1 Limits Multiple Myeloma Disease Progression In Vivo. Cancers. 12(8). 2149–2149. 10 indexed citations
12.
Zeissig, Mara N., D. Hewett, Vasilios Panagopoulos, et al.. (2020). Expression of the chemokine receptor CCR1 promotes the dissemination of multiple myeloma plasma cells <i>in vivo</i>. Haematologica. 106(12). 3176–3187. 18 indexed citations
13.
Cheong, Chee Man, Krzysztof M. Mrozik, D. Hewett, et al.. (2020). Twist-1 is upregulated by NSD2 and contributes to tumour dissemination and an epithelial-mesenchymal transition-like gene expression signature in t(4;14)-positive multiple myeloma. Cancer Letters. 475. 99–108. 27 indexed citations
14.
Noll, Jacqueline E., Kimberley C. Clark, Krzysztof M. Mrozik, et al.. (2020). GLIPR1 expression is reduced in multiple myeloma but is not a tumour suppressor in mice. PLoS ONE. 15(1). e0228408–e0228408. 4 indexed citations
15.
Mrozik, Krzysztof M., Orest W. Blaschuk, Chee Man Cheong, Andrew C.W. Zannettino, & Kate Vandyke. (2018). N-cadherin in cancer metastasis, its emerging role in haematological malignancies and potential as a therapeutic target in cancer. BMC Cancer. 18(1). 939–939. 253 indexed citations
16.
Hewett, D., Kate Vandyke, David Lawrence, et al.. (2017). DNA Barcoding Reveals Habitual Clonal Dominance of Myeloma Plasma Cells in the Bone Marrow Microenvironment. Neoplasia. 19(12). 972–981. 16 indexed citations
17.
Hemming, Sarah, Dimitrios Cakouros, Kate Vandyke, et al.. (2016). Identification of Novel EZH2 Targets Regulating Osteogenic Differentiation in Mesenchymal Stem Cells. Stem Cells and Development. 25(12). 909–921. 64 indexed citations
18.
Cheong, Chee Man, Stephen Fitter, D. Hewett, et al.. (2015). Tetraspanin 7 (TSPAN7) expression is upregulated in multiple myeloma patients and inhibits myeloma tumour development in vivo. Experimental Cell Research. 332(1). 24–38. 34 indexed citations
19.
Noll, Jacqueline E., D. Hewett, Sharon A. Williams, et al.. (2014). SAMSN1 Is a Tumor Suppressor Gene in Multiple Myeloma. Neoplasia. 16(7). 572–585. 37 indexed citations
20.
Vandyke, Kate, P. Jackson, A. Shaun Rowe, Pamela J. Russell, & Julie M. Blair. (2006). Androgen decreases osteoprotegerin expression in prostate cancer cells. Prostate Cancer and Prostatic Diseases. 10(2). 160–166. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B Nico Breakdown of academic impact, for papers by Dora Višnjić Breakdown of academic impact, for papers by Fotis Asimakopoulos Breakdown of academic impact, for papers by Isabelle Vande Broek Breakdown of academic impact, for papers by Sophia K. Khaldoyanidi Breakdown of academic impact, for papers by Marina Bolzoni Breakdown of academic impact, for papers by Quteba Ebrahem Breakdown of academic impact, for papers by Natasha M. Savage Breakdown of academic impact, for papers by Sabrina Bonomini Breakdown of academic impact, for papers by Ryohichi Sugimura
Rankless by CCL
2026